Clearside Biomedical extension study of PEACHTREE for Xipere shows durability
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bausch Health and Clearside Biomedical announce results from Peachtree study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clearside Biomedical presents results from MAGNOLIA Phase 3 extension study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clearside Biomedical announces resubmission of NDA for XIPERE
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clearside Biomedical targets NDA resubmission for XIPERE in 4Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clearside Biomedical revises NDA resubmission timeline for XIPERE
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bausch Health acquires exclusive license for Xipere from Clearside Biomedical
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clearside Biomedical plans to resubmit XIPERE NDA in 1Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Laidlaw downgrades Clearside Biomedical to Hold after Xipere partnering
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clearside Biomedical Plunges 60% Following Phase 3 Study Results
Shares of Clearside Biomedical Inc (NASDAQ: CLSD), a biopharmaceutical company that focuses on the treatment of serious eye diseases, plunged 60 percent Monday after announcing read more.....»»
Clearside Biomedical submits Xipere NDA to FDA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rare Disease-Focused-Ultragenyx Pharmaceutical Stock Falls On Serious Adverse Events In Eaarly Genetic Disorder Study
New data from Phase 1/2 study of GTX-102 for Angelman syndrome shows rapid and sustained improvement in patients, exceeding natural history data. read more.....»»
Remote workers are about to get a rude awakening
A new study shows that moving away from a big city can be bad for your career. Marco Bottigelli/Getty, Yevgen Romanenko/Getty, Maskot/Getty, Tyler Le/BIEver since hordes of Americans began fleeing big coastal cities during the.....»»
Annovis jumps after Alzheimer"s drug shows 30% cognitive improvement in study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adaptimmune"s Stock Trades Higher As TCR Therapy Shows Initial Durability In Soft Tissue Cancer Settings
read more.....»»
Aveo Pharmaceuticals" ph3 study of FOTIVDA saw higher durability of response
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clearside Biomedical price target raised to $9 from $8 at Roth Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clearside Biomedical reports Q1 EPS (10c), consensus (13c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
If you want to eat like your paleo ancestors, stop cutting out all carbs, a new study suggests
Advocates of the paleo diet assume that our human ancestors had a meat-heavy, low-carb diet. But research shows Neanderthals ate many starchy foods. An employee of the Natural History Museum i.....»»
CureVac-GSK"s Second-Gen COVID-19 Vaccine Candidate Shows Encouraging Action Against Variants In Animal Study
read more.....»»
: Mixing Pfizer and AstraZeneca COVID-19 vaccines increases mild side effects but is safe, study shows
Mixing doses of COVID-19 vaccines increases the risk of mild to moderate side effects when compared with administering two shots of the same vaccine, according to a U.K. trial......»»